Capital World Investors 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 1:24 pm Sale | 2021-02-16 | 13G | Ultragenyx Pharmaceutical Inc. RARE | Capital World Investors | 3,129,724 4.700% | -107,571 (-3.32%) | Filing |